Simplex Trading, LLC Bio Line Rx Ltd. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$1.03 - $1.56 $2,043 - $3,095	1,984 New	1,984 $2,000
Q4 2022 Feb 02, 2023	SELL	$0.57 - $0.95 $56 - $95	-100 Reduced 48.54%	106 $0
Q3 2022 Nov 04, 2022	SELL	$0.88 - $1.91 $1,345 - $2,920	-1,529 Reduced 88.13%	206 $0
Q2 2022 Aug 03, 2022	BUY	$1.06 - $1.82 $174 - $300	165 Added 10.51%	1,735 $2,000
Q1 2022 May 02, 2022	SELL	$1.46 - $2.18 $9,714 - $14,505	-6,654 Reduced 80.91%	1,570 $2,000
Q4 2021 Feb 23, 2022	BUY	$1.98 - $3.06 $16,283 - $25,165	8,224 New	8,224 $16,000

3.35M

46.5K

6.3K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $13.5M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.